Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,198 | 38,044 | 69,275 | N/A | N/A |
| Marketable Securities | 61,072 | 60,311 | 50,710 | N/A | N/A |
| Receivables | 53,530 | 61,813 | 43,306 | N/A | N/A |
| Inventories | 33,008 | 29,759 | 32,305 | N/A | N/A |
| Income taxes - deferred | 25,943 | 21,607 | 17,900 | N/A | N/A |
| Other current assets | 14,474 | 14,136 | 13,578 | 0 | 0 |
| TOTAL | $233,284 | $230,041 | $236,372 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 95,844 | 95,914 | 95,629 | N/A | N/A |
| Intangibles | 27,574 | 27,574 | 27,574 | 0 | 0 |
| Other Non-Current Assets | 159,303 | 158,602 | 154,712 | 0 | 0 |
| TOTAL | $282,721 | $282,090 | $277,915 | $N/A | $N/A |
| Total Assets | $516,005 | $512,131 | $514,287 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,887 | 14,536 | 14,416 | N/A | N/A |
| Accounts payable and accrued liabilities | 14,180 | 11,795 | 12,797 | 0 | 0 |
| Accrued Expenses | 44,503 | 34,811 | 41,360 | N/A | N/A |
| TOTAL | $98,536 | $101,315 | $109,588 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,065 | 5,531 | 5,990 | N/A | N/A |
| Deferred Revenues | 37,966 | 37,173 | 35,015 | N/A | N/A |
| Other Non-Current Liabilities | 15,195 | 14,227 | 13,255 | 0 | 0 |
| TOTAL | $246,204 | $247,912 | $245,049 | $N/A | $N/A |
| Total Liabilities | $344,740 | $349,227 | $354,637 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,511 | 60,657 | N/A | N/A | N/A |
| Common Shares | 617 | 608 | 602 | N/A | N/A |
| Retained earnings | -44,001 | -47,014 | -49,233 | N/A | N/A |
| Other shareholders' equity | -843 | -1,557 | -847 | 0 | 0 |
| TOTAL | $171,265 | $162,904 | $159,650 | $N/A | $N/A |
| Total Liabilities And Equity | $516,005 | $512,131 | $514,287 | $0 | $0 |